Literature DB >> 82839

Alpha2-plasmin-inhibitor deficiency (Miyasato disease).

K Koie, T Kamiya, K Ogata, J Takamatsu.   

Abstract

A 25-year-old man, born in Okinawa, Japan, had a haemorrhagic diathesis characterised by prolonged bleeding and ecchymoses after minor trauma and spontaneous joint haemorrhage. The frequency and severity of these episodes were reduced by an antiplasminic drug. Routine coagulation studies revealed no abnormalities except for significantly sshortened euglobulin-lysis time and whole-blood clot lysis time. Activities of all known clotting and fibrinolytic factors were within normal ranges but no circulating alpha2-plasmin inhibitor was found in the plasma. alpha2-plasmin inhibitor is a potent and fast-acting protease inhibitor. Studies of family members indicated that this abnormality was inherited as an autosomal and recessive gene.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82839     DOI: 10.1016/s0140-6736(78)91973-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  A bleeding disorder due to deficiency of alpha 2-antiplasmin.

Authors:  P Kettle; E E Mayne
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

2.  Biological role of fibrinolysis.

Authors:  J F Davidson; I D Walker
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

Review 3.  Clinical disorders of fibrinolysis: a critical review.

Authors:  R B Francis
Journal:  Blut       Date:  1989-07

4.  Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease.

Authors:  Satish Singh; Sofiyan Saleem; Guy L Reed
Journal:  Front Cardiovasc Med       Date:  2020-12-23

Review 5.  Bleeding Disorders in Primary Fibrinolysis.

Authors:  Massimo Franchini; Marco Zaffanello; Pier Mannuccio Mannucci
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.